Surpass Streamline血流导向术对颅内动脉瘤的疗效  

The efficacy of Surpass Streamline flow diversion for intracraniaIal neurysms

作　　者：黄爱强 孟磊 刘正[1] HUANG Aiqiang;MENG Lei;LIU Zheng(Department of Neurosurgery,Affiliated Suzhou Hospital,Anhui Medical University Suzhou,Anhui Province 234000,China)

机构地区：[1]安徽医科大学附属宿州医院神经外科,安徽宿州234000

出　　处：《介入放射学杂志》2024年第3期285-288,共4页Journal of Interventional Radiology

摘　　要：目的了解Surpass Streamline血流导向术对颅内动脉瘤的疗效。方法选取2020年1月至2022年1月安徽医科大学附属宿州医院68例接受Surpass Streamline血流导向装置治疗的颅内动脉瘤患者。收集临床资料,观察患者术前术后血流动力学参数变化,以及术前和术后3、6、12个月的改良Rankin量表(mRS)评分变化,分析患者的影像学资料,观察动脉瘤闭塞情况。结果与术前相比较,患者术后的WSS、瘤颈血流速度降低,LSA、RRT、载瘤动脉及患侧M1的血流速度增加(P<0.05),而患者术前、术后对侧M1血流速度比较差异无统计学意义(P>0.05)。术后,随着时间的延长,患者的mRS评分为低级别占比逐渐增高,差异有统计学意义(P<0.05)。术后6个月及12个月患者的支架内狭窄发生率分别为7.35%、8.82%,动脉瘤完全闭塞发生率分别为52.94%、63.24%,差异无统计学意义(P>0.05)。68例患者经Surpass Streamline血流导向术治疗后,4例出现缺血性并发症,其中2例表现为视物模糊、皮质盲,1例为肢体无力,1例支架内血栓,经干预治疗均得到有效缓解。结论采用Surpass Streamline血流导向术治疗颅内动脉瘤有较好的疗效,能改善血流动力学,术后动脉瘤完全闭塞率较高,且安全性较好,值得临床推广。Objective To make a further understanding of the curative efficacy of Surpass Streamline flow diversion treatment for intracranial aneurysms.Methods The clinical data of a total of 68 patients with intracranial aneurysm,who received Surpass Streamline flow diverter treatment at the Affiliated Suzhou Hospital of Anhui Medical University of China between January 2020 and January 2022,were retrospectively analyzed.The preoperative and postoperative changes in hemodynamic parameters,and the preoperative and postoperative 3-,6-,and 12-month modified Rankin Scale(mRS)scores were collected.The imaging findings were analyzed,and the status of aneurysm occlusion was determined.Results Compared with the preoperative values,the postoperative blood flow velocity at the WSS and the tumor neck was decreased,while the blood flow velocity of LSA,RRT,tumor carrier artery and M1 on the affected side was increased(P<0.05),and the blood flow velocity of M1 on the healthy side showed no significant change(P>0.05).After surgery,the proportion of patients with low-grade mRS score gradually increased with the time passing,and the difference was statistically significant(P<0.05).The postoperative 6-month and 12-month incidences of instent stenosis were 7.35%and 8.82%respectively,incidences of aneurysmal complete occlusion were 52.94%and 63.24%respectively,and the differences were not statistically significant(P>0.05).Of the 68 patients having been treated with Surpass Streamline flow diverter,4 patients developed ischemic complications,and 2 of the4 presented with blurred vision and cortical blindness,one patient had limb weakness and one patient had a in-stent thrombus,all of which were effectively relieved after intervention therapy.Conclusion For the treatment of intracranial aneurysms,Surpass Streamline flow diversion treatment has good efficacy,it can improve hemodynamics,besides,it carries high postoperative complete aneurysmal occlusion rate with satisfactory safety.Therefore,this technique is worthy of clinical popularization.

关 键 词：颅内动脉瘤 Surpass Streamline血流导向术 术后栓塞 神经功能 动脉瘤闭塞 

分 类 号：R651.11[医药卫生—外科学]